Vice President of Revenue Cycle Management, Freenome
$261.7-337.8k
Plus equity and cash bonuses
More information about location
Biological analysis platform for cancer
Be an early applicant
Biological analysis platform for cancer
501-1000 employees
Be an early applicant
$261.7-337.8k
Plus equity and cash bonuses
More information about location
501-1000 employees
Company mission
To create tools that empower everyone to prevent, detect, and treat their disease.
Role
Who you are
- Bachelor’s degree in finance, healthcare administration, or a related field (MBA or MHA preferred)
- 12+ years of progressive experience in revenue cycle management, preferably in molecular diagnostics or precision diagnostics industry
- 6+ years leadership experience in revenue cycle management building and leading high-performance teams
- 4+ years of P&L responsibility
- Extensive expertise in payer contracting, reimbursement methodologies, and healthcare finance
- Proven success in scaling revenue cycle operations for a growing healthcare organization
- Passion for utilizing AI and automation to optimize systems and processes
- Strong planning and cross-functional partnership skills with demonstrated ability to drive continuous improvement
- Deep understanding of compliance (CMS, HIPAA, Stark Law, etc.) and regulatory considerations in infusion services
What the job involves
- The Vice President, Revenue Cycle Management will build, lead and oversee all aspects of revenue cycle operations, ensuring compliance, efficiency, and strategic optimization of patient intake, financial counseling, billing, collections, reimbursement, and financial workflows
- This executive will design and implement scalable, AI-enabled automated revenue cycle infrastructure in partnership with Sales, Market Access, and Commercial Operations to maximize revenue capture, minimize denials, and enhance patient financial experience
- This position reports to the Chief Financial Officer (CFO)
- Strategic Leadership: Develop and implement Freenome’s enterprise-wide revenue cycle strategy
- People Leadership: Build, coach, and develop a high-performing team, fostering a culture of accountability, continuous improvement, and deep customer focus
- Billing & Collections: Establish and oversee all processes related to coding, claims submission, reimbursement, and accounts receivable management
- Patient Intake Services: Oversee the efficiency and effectiveness of intake services including benefit verification, financial counseling, prior authorization, and customer call center operations
- Payer & Contracting Relations: Partner with Market Access to maintain strong payer relationships, ensuring optimal reimbursement rates and contract compliance
- Compliance & Risk Management: Ensure adherence to federal, state, and payer-specific regulations, including CMS and value-based care initiatives
- AI, Technology & Process Optimization: Leverage AI, ML, automation, and analytics to improve revenue cycle performance, reduce denials, intake time and overall cost to collect
- Cross-Functional Collaboration: Partner with Sales, Market Access and Commercial Operations leadership to ensure smooth revenue cycle integration with patient care workflows
- Financial Performance Monitoring: Define, track, and analyze revenue cycle KPIs, drive continuous improvement, and present strategic insights and actionable recommendations to executive leadership
- Budget Oversight: Oversee annual budget, ensuring effective allocation of resources to meet organization objectives
- Customer Engagement: Build strong relationships with customers by proactively addressing financial challenges and aligning solutions with their operational and clinical needs
- Organization Leadership: Serve as a trusted and key contributor to the Finance organization and Senior Leadership Team, actively participating in Quarterly Business Reviews (QBRs) and providing strategic insights on revenue cycle performance, reimbursement optimization, and payer trends
Our take
Freenome is a biotechnology company offering a biological analysis platform that uses molecular biology and machine learning to detect cancer with a routine blood draw. The platform trains on thousands of cancer-positive blood samples to recognise disease-associated patterns and help detect early-stage cancer, allowing clinicians to optimise treatments.
The company specialises in advanced computational biology, using machine learning to detect patterns among billions of circulating cell-free biomarkers. Freenome continues to focus on the development of its colorectal cancer test, potentially helping the 45 million people not currently up-to-date on colorectal cancer screening guidelines in the United States.
Following its 2022 funding round, the company surpassed the $1 billion funding mark. Freenome is set to accelerate the development of its platform, testing for additional cancers and furthering its blood test detection technology. It's also forming partnerships for R&D purposes, joining forces with health firms such as Geisinger to provide real-world data that could help it detect multiple cancers.
Steph
Company Specialist at Welcome to the Jungle
Insights
14% employee growth in 12 months
Company
Funding (last 2 of 8 rounds)
Nov 2025
$75m
LATE VC
Feb 2024
$254m
LATE VC
Total funding: $1.1bn
Company HQ
The East Side, South San Francisco, CA
Leadership
Riley Ennis
(Co-Founder)Studied at Yale, Johns Hopkins and Dartmouth. Was a Thiel Fellow and co-founded Immudicon and Oncolinx.
Share this job
View 7 more jobs at Freenome